查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566963

虾青素市场：按来源、形式和应用分类：2024-2033 年全球机会分析和产业预测

Astaxanthin Market By Source (Natural, Synthetic) , By Form (Dry, Liquid) By Application (Dietary supplements, Cosmetics, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
简介目录

虾虾青素市场

2023年虾青素市值为8亿美元，预计2024年至2033年复合年增长率为8.1%，到2033年将达16亿美元。

虾青素是一种红色素，属于叶黄素类胡萝卜素类别，存在于多种微生物和海洋生物中。虾青素以其抗氧化特性而闻名，并能保护细胞免受自由基的侵害。这种化合物以补充品的形式食用，可以促进大脑、眼睛和皮肤健康，调节高胆固醇水平，并支持免疫系统。此外，虾青素也用于水产养殖业，将色素添加到养殖的鳟鱼、鲑鱼和虾中。这个过程改善了水产养殖产品的外观并增加了其市场规模。

人们对健康生活方式和膳食食品重要性的认识不断提高，是虾青素市场的关键驱动因素。此外，由于虾青素是一种天然产品，由于人们对有机或天然产品的青睐激增，补充品和化妆品行业对虾红素的需求量很大。未来，在作物生产中利用虾青素的趋势预计将获得巨大的推动力。根据科学组合 SpringerLink 发表的一篇论文，将虾青素应用于水稻幼苗可以消除氧化压力，调节体内平衡，并提高耐盐性。

然而，高剂量虾青素引起的消化器官系统疾病等副作用的潜在风险阻止了一些人的消费并阻碍了市场成长。此外，从自然资源中提取虾青素正逐渐导致微藻类和其他海洋生物的消耗。这一因素阻碍了虾青素在多种应用中的使用。相反，为了应对资源枯竭的挑战，世界各地成立了多家微藻类生产公司，将虾青素生产转移到实验室。截至2022年9月，欧盟委员会已认定欧洲17个国家的87家公司。这些公司使用反应器来培养产生虾青素的微藻类。从这些培养的微藻类中提取虾青素具有多种优点，例如减少环境污染、可扩展性机会以及减少自然资源的开采。

分部审查

虾青素市场分为来源、形式、应用和地区。根据来源，市场分为天然和合成。依形态的不同，可分为干燥的和液体的。依用途分为营养食品、化妆品等。从区域来看，分析包括北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

主要发现

从来源来看，天然细分市场在 2023 年占据主导地位。

从业态来看，干燥区隔市场将在 2023 年占据较高的市场。

从应用来看，到 2033 年，食品领域预计将占高比例。

按地区划分，北美地区 2023 年收益最高。

可以使用此报告进行客製化（需要额外费用和时间表）

  • 国家、区域和全球各级的患者/流行病学资料
  • 监管指引
  • 针对客户兴趣的其他公司简介
  • 扩大公司简介列表
  • 历史市场资料
  • SWOT分析

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章虾青素市场：依来源分类

  • 市场概况
  • 自然的
  • 合成

第五章虾青素市场：依形式

  • 市场概况
  • 干法
  • 液体

第六章虾青素市场：依应用分类

  • 市场概况
  • 食品补充品
  • 化妆品
  • 其他的

第七章虾青素市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国虾青素市场
    • 加拿大虾虾青素市场
    • 墨西哥虾虾青素市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国虾虾青素市场
    • 德国虾虾青素市场
    • 义大利虾虾青素市场
    • 西班牙虾虾青素市场
    • 英国虾青素市场
    • 其他欧洲虾虾青素市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国虾青素市场
    • 日本虾虾青素市场
    • 印度虾虾青素市场
    • 韩国虾虾青素市场
    • 澳洲虾青素市场
    • 其他亚太地区虾虾青素市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西虾虾青素市场
    • 南非虾虾青素市场
    • 沙乌地阿拉伯虾虾青素市场
    • 其他拉丁美洲/中东/非洲虾虾青素市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • INNOBIO Limited
  • Divis Laboratories Limited
  • Algaecan Biotech
  • ALGA Technologies
  • Cyanotech Corporation.
  • Otsuka Pharmaceutical Co.
  • Cardax
  • Fenchem
  • BGG
  • Fuji Chemical Industries Company Limited
简介目录
Product Code: A324369

Astaxanthin Market

The astaxanthin market was valued at $0.8 billion in 2023 and is projected to reach $1.6 billion by 2033, growing at a CAGR of 8.1% from 2024 to 2033.

Astaxanthin is a red-colored pigment that belongs to the category of xanthophyll carotenoid and is present in several microorganisms and marine organisms. Astaxanthin is known for its antioxidant properties and aids in the protection of cells from free radicals. The compound is consumed in the form of supplements to enhance the health of brain, eyes, & skin; regulate high cholesterol levels; and support the immune system. Moreover, astaxanthin is used in the aquaculture industry to integrate pigmentation into farmed trout, salmons, and shrimps. This process elevates the appearance of aquaculture products and enhances their market value.

Increase in awareness regarding fit lifestyle and importance of health supplements is a significant driver of the astaxanthin market. In addition, astaxanthin is a natural product due to which it witnesses a high demand from the supplements and cosmetics industries, owing to surge in inclination toward organic or natural products. In the coming future, the trend of utilizing astaxanthin in crop production is anticipated to acquire notable traction. As per an article published by SpringerLink, a scientific portfolio, application of astaxanthin into rice seedlings eliminates their oxidative stress, regulates their homeostatic balance, and boosts their tolerance toward salinity.

However, the potential risk of side effects, such as disturbances in digestive system, due to high dosage of astaxanthin deters several individuals from its consumption and hampers the growth of the market. Furthermore, the extraction of astaxanthin from natural resources is gradually resulting in the depletion of microalgae and other marine organisms. This factor discourages the use of astaxanthin in diverse applications. Contrarily, to address the challenge of resource depletion, several microalgae-producing enterprises have been established across the globe to shift the production of astaxanthin into laboratories. As of September 2022, the European Commission identified 87 enterprises in 17 countries of Europe. These enterprises cultivate the astaxanthin-producing microalgae using photobioreactors. The extraction of astaxanthin from these cultured microalgae offers several benefits such as decreased environmental pollution, availability of scalability opportunities, and reduced exploitation of natural resources.

Segment Review

The astaxanthin market is divided into source, form, application, and region. On the basis of source, the market is bifurcated into natural and synthetic. As per form, it is divided into dry and liquid. Depending on application, it is classified into dietary supplements, cosmetics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of source, the natural segment dominated the market in 2023.

As per form, the dry segment acquired a high stake in the market in 2023.

Depending on application, the dietary supplements segment is projected to account for a high share of the market by 2033.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The key players operating in the global astaxanthin market include INNOBIO Limited, Divis Laboratories Limited, Algaecan Biotech, ALGA Technologies, Cyanotech Corporation., Otsuka Pharmaceutical Co., Cardax, Fenchem, BGG, and Fuji Chemical Industries Company Limited. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Source

  • Natural
  • Synthetic

By Form

  • Dry
  • Liquid

By Application

  • Dietary supplements
  • Cosmetics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • INNOBIO Limited
    • Divis Laboratories Limited
    • Algaecan Biotech
    • ALGA Technologies
    • Cyanotech Corporation.
    • Otsuka Pharmaceutical Co.
    • Cardax
    • Fenchem
    • BGG
    • Fuji Chemical Industries Company Limited

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ASTAXANTHIN MARKET, BY SOURCE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Source
  • 4.2. Natural
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Synthetic
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ASTAXANTHIN MARKET, BY FORM

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Form
  • 5.2. Dry
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Liquid
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: ASTAXANTHIN MARKET, BY APPLICATION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Application
  • 6.2. Dietary Supplements
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Cosmetics
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: ASTAXANTHIN MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Source
    • 7.2.3. Market Size and Forecast, By Form
    • 7.2.4. Market Size and Forecast, By Application
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Astaxanthin Market
      • 7.2.6.1. Market Size and Forecast, By Source
      • 7.2.6.2. Market Size and Forecast, By Form
      • 7.2.6.3. Market Size and Forecast, By Application
    • 7.2.7. Canada Astaxanthin Market
      • 7.2.7.1. Market Size and Forecast, By Source
      • 7.2.7.2. Market Size and Forecast, By Form
      • 7.2.7.3. Market Size and Forecast, By Application
    • 7.2.8. Mexico Astaxanthin Market
      • 7.2.8.1. Market Size and Forecast, By Source
      • 7.2.8.2. Market Size and Forecast, By Form
      • 7.2.8.3. Market Size and Forecast, By Application
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Source
    • 7.3.3. Market Size and Forecast, By Form
    • 7.3.4. Market Size and Forecast, By Application
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Astaxanthin Market
      • 7.3.6.1. Market Size and Forecast, By Source
      • 7.3.6.2. Market Size and Forecast, By Form
      • 7.3.6.3. Market Size and Forecast, By Application
    • 7.3.7. Germany Astaxanthin Market
      • 7.3.7.1. Market Size and Forecast, By Source
      • 7.3.7.2. Market Size and Forecast, By Form
      • 7.3.7.3. Market Size and Forecast, By Application
    • 7.3.8. Italy Astaxanthin Market
      • 7.3.8.1. Market Size and Forecast, By Source
      • 7.3.8.2. Market Size and Forecast, By Form
      • 7.3.8.3. Market Size and Forecast, By Application
    • 7.3.9. Spain Astaxanthin Market
      • 7.3.9.1. Market Size and Forecast, By Source
      • 7.3.9.2. Market Size and Forecast, By Form
      • 7.3.9.3. Market Size and Forecast, By Application
    • 7.3.10. UK Astaxanthin Market
      • 7.3.10.1. Market Size and Forecast, By Source
      • 7.3.10.2. Market Size and Forecast, By Form
      • 7.3.10.3. Market Size and Forecast, By Application
    • 7.3.11. Rest of Europe Astaxanthin Market
      • 7.3.11.1. Market Size and Forecast, By Source
      • 7.3.11.2. Market Size and Forecast, By Form
      • 7.3.11.3. Market Size and Forecast, By Application
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Source
    • 7.4.3. Market Size and Forecast, By Form
    • 7.4.4. Market Size and Forecast, By Application
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Astaxanthin Market
      • 7.4.6.1. Market Size and Forecast, By Source
      • 7.4.6.2. Market Size and Forecast, By Form
      • 7.4.6.3. Market Size and Forecast, By Application
    • 7.4.7. Japan Astaxanthin Market
      • 7.4.7.1. Market Size and Forecast, By Source
      • 7.4.7.2. Market Size and Forecast, By Form
      • 7.4.7.3. Market Size and Forecast, By Application
    • 7.4.8. India Astaxanthin Market
      • 7.4.8.1. Market Size and Forecast, By Source
      • 7.4.8.2. Market Size and Forecast, By Form
      • 7.4.8.3. Market Size and Forecast, By Application
    • 7.4.9. South Korea Astaxanthin Market
      • 7.4.9.1. Market Size and Forecast, By Source
      • 7.4.9.2. Market Size and Forecast, By Form
      • 7.4.9.3. Market Size and Forecast, By Application
    • 7.4.10. Australia Astaxanthin Market
      • 7.4.10.1. Market Size and Forecast, By Source
      • 7.4.10.2. Market Size and Forecast, By Form
      • 7.4.10.3. Market Size and Forecast, By Application
    • 7.4.11. Rest of Asia-Pacific Astaxanthin Market
      • 7.4.11.1. Market Size and Forecast, By Source
      • 7.4.11.2. Market Size and Forecast, By Form
      • 7.4.11.3. Market Size and Forecast, By Application
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Source
    • 7.5.3. Market Size and Forecast, By Form
    • 7.5.4. Market Size and Forecast, By Application
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Astaxanthin Market
      • 7.5.6.1. Market Size and Forecast, By Source
      • 7.5.6.2. Market Size and Forecast, By Form
      • 7.5.6.3. Market Size and Forecast, By Application
    • 7.5.7. South Africa Astaxanthin Market
      • 7.5.7.1. Market Size and Forecast, By Source
      • 7.5.7.2. Market Size and Forecast, By Form
      • 7.5.7.3. Market Size and Forecast, By Application
    • 7.5.8. Saudi Arabia Astaxanthin Market
      • 7.5.8.1. Market Size and Forecast, By Source
      • 7.5.8.2. Market Size and Forecast, By Form
      • 7.5.8.3. Market Size and Forecast, By Application
    • 7.5.9. Rest of LAMEA Astaxanthin Market
      • 7.5.9.1. Market Size and Forecast, By Source
      • 7.5.9.2. Market Size and Forecast, By Form
      • 7.5.9.3. Market Size and Forecast, By Application

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. INNOBIO Limited
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Divis Laboratories Limited
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Algaecan Biotech
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. ALGA Technologies
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Cyanotech Corporation.
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Otsuka Pharmaceutical Co.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Cardax
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Fenchem
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. BGG
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Fuji Chemical Industries Company Limited
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments